August 29, 2015 – This may after all not be so good news for Type 2-Diabetes patients on DPP-4 inhibitor medications. The American Food and Drug Administration (FDA) is warning that the type 2 diabetes medicines containing the pharmacologically active …

Drug Safety Communication: DPP-4 inhibitors for Type 2-Diabetes may cause severe joint pain Read more »

April 13, 2014 – The American Food and Drug Administration (FDA) has issued a new Boxed Warning for Valproic Acid [Stavzor] and its association with drug induced liver disease (hepatotoxicity, hepatic failure) which may be fatal in some patients. We …

Valproic Acid [Stavzor]: Newly issued boxed warning for life-threatening liver disease Read more »